- Home
- ZLAB vs WEN Comparison
ZLAB vs WEN Comparison
Compare ZLAB & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- WEN
- Stock Information
- Founded
- ZLAB 2013
- WEN 1969
- Country
- ZLAB China
- WEN United States
- Employees
- ZLAB N/A
- WEN N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- WEN Restaurants
- Sector
- ZLAB Health Care
- WEN Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- WEN Nasdaq
- Market Cap
- ZLAB 3.5B
- WEN 3.1B
- IPO Year
- ZLAB 2017
- WEN N/A
- Fundamental
- Price
- ZLAB $29.24
- WEN $12.00
- Analyst Decision
- ZLAB Buy
- WEN Hold
- Analyst Count
- ZLAB 4
- WEN 18
- Target Price
- ZLAB $47.37
- WEN $16.69
- AVG Volume (30 Days)
- ZLAB 1.2M
- WEN 5.2M
- Earning Date
- ZLAB 05-08-2025
- WEN 05-02-2025
- Dividend Yield
- ZLAB N/A
- WEN 7.42%
- EPS Growth
- ZLAB N/A
- WEN N/A
- EPS
- ZLAB N/A
- WEN 0.94
- Revenue
- ZLAB $418,326,000.00
- WEN $2,235,211,000.00
- Revenue This Year
- ZLAB $44.43
- WEN $1.05
- Revenue Next Year
- ZLAB $48.68
- WEN $4.27
- P/E Ratio
- ZLAB N/A
- WEN $12.75
- Revenue Growth
- ZLAB 43.72
- WEN 2.18
- 52 Week Low
- ZLAB $15.65
- WEN $11.70
- 52 Week High
- ZLAB $39.77
- WEN $20.60
- Technical
- Relative Strength Index (RSI)
- ZLAB 42.71
- WEN 33.73
- Support Level
- ZLAB $27.61
- WEN $11.70
- Resistance Level
- ZLAB $32.02
- WEN $13.06
- Average True Range (ATR)
- ZLAB 1.23
- WEN 0.37
- MACD
- ZLAB -0.18
- WEN 0.01
- Stochastic Oscillator
- ZLAB 23.41
- WEN 22.06
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About WEN Wendy's Company (The)
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.3 billion in 2023, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($53.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned almost 7,157 total stores in 30 countries as of year-end 2023. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.